TR200002593T2 - Yeni bir gebelik önleme kiti - Google Patents

Yeni bir gebelik önleme kiti

Info

Publication number
TR200002593T2
TR200002593T2 TR2000/02593T TR200002593T TR200002593T2 TR 200002593 T2 TR200002593 T2 TR 200002593T2 TR 2000/02593 T TR2000/02593 T TR 2000/02593T TR 200002593 T TR200002593 T TR 200002593T TR 200002593 T2 TR200002593 T2 TR 200002593T2
Authority
TR
Turkey
Prior art keywords
steroids
kit
new
contraceptive
profile
Prior art date
Application number
TR2000/02593T
Other languages
English (en)
Inventor
Jan Klooster Helenius
Hermanus Johanna Deckers Godefridus
Antonius Maria Hamersma Johannes
Michiel Verbost Pieter
Jan Tijmen Coelingh Bennink Herman
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of TR200002593T2 publication Critical patent/TR200002593T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Bulus, gebelik önleyici bir maddenin günlük olarak uygulanmasi için vasitalar içeren bir gebelik önleme kitine iliskindir; kitin özelligi, içinde bulunan gebelik önleyici tek maddenin, progestagenik ve östrojenik aktiviteyi dogal olarak birlestiren bir aktivite profiline sahip bir steroid bilesik olmasidir. Bilinen steroid bilesiklerin olusturdugu genel sinif içinde, özellikle monoterapi yoluyla gebelik önlemede kullanilmak üzere biyolojik özelliklerin belirgin bir kombine profiline sahip steroidler bulunmustur. Bu steroidler, nokta nokta çizgilerin herbirinin, bagimsiz olarak seçime bagli bir bagi gösterdigi yapisal formül 8I)'i karsilayan steroidler ve bunlarin ön-ilaçlarindan olusan gruptan seçilir.
TR2000/02593T 1998-03-09 1999-03-03 Yeni bir gebelik önleme kiti TR200002593T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98200744 1998-03-09

Publications (1)

Publication Number Publication Date
TR200002593T2 true TR200002593T2 (tr) 2000-12-21

Family

ID=8233452

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02593T TR200002593T2 (tr) 1998-03-09 1999-03-03 Yeni bir gebelik önleme kiti

Country Status (20)

Country Link
EP (1) EP1061928A2 (tr)
JP (1) JP2002506014A (tr)
KR (1) KR20010041698A (tr)
CN (1) CN1292702A (tr)
AR (1) AR018313A1 (tr)
AU (1) AU756882B2 (tr)
BR (1) BR9908605A (tr)
CA (1) CA2319765A1 (tr)
CO (1) CO5070598A1 (tr)
HU (1) HUP0101007A3 (tr)
ID (1) ID25621A (tr)
IL (1) IL137541A0 (tr)
NO (1) NO20004492L (tr)
NZ (1) NZ506115A (tr)
PE (1) PE20000330A1 (tr)
PL (1) PL343428A1 (tr)
RU (1) RU2225714C2 (tr)
TR (1) TR200002593T2 (tr)
WO (1) WO1999045886A2 (tr)
ZA (1) ZA991851B (tr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999051214A2 (en) * 1998-04-07 1999-10-14 Akzo Nobel N.V. Progestogen-only contraceptive kit
MXPA02001831A (es) 1999-09-06 2002-10-23 Akzo Nobel Nv Esteroides estrogenicos no aromaticos con un sustituyente de hidrocarburo en posicion 11.
AU8201601A (en) 2000-07-28 2002-02-13 Akzo Nobel Nv 16alpha-methyl or ethyl substituted estrogens
EP1482949A1 (en) * 2002-03-11 2004-12-08 Janssen Pharmaceutica N.V. Sulfatase inhibiting progestogen-only contraceptive regimens
AU2003213842A1 (en) * 2002-03-11 2003-09-29 Janssen Pharmaceutica N.V. Sulfatase inhibiting continuous progestogen contraceptive regimens
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7701384A (nl) * 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
DE4227989A1 (de) * 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints

Also Published As

Publication number Publication date
NO20004492D0 (no) 2000-09-08
NO20004492L (no) 2000-09-08
WO1999045886A3 (en) 1999-12-02
ID25621A (id) 2000-10-19
AU756882B2 (en) 2003-01-23
RU2225714C2 (ru) 2004-03-20
NZ506115A (en) 2003-07-25
JP2002506014A (ja) 2002-02-26
AU3143799A (en) 1999-09-27
CO5070598A1 (es) 2001-08-28
PL343428A1 (en) 2001-08-13
CN1292702A (zh) 2001-04-25
BR9908605A (pt) 2001-04-24
ZA991851B (en) 1999-09-22
HUP0101007A2 (hu) 2001-12-28
WO1999045886A2 (en) 1999-09-16
IL137541A0 (en) 2001-07-24
AR018313A1 (es) 2001-11-14
CA2319765A1 (en) 1999-09-16
EP1061928A2 (en) 2000-12-27
KR20010041698A (ko) 2001-05-25
PE20000330A1 (es) 2000-05-16
HUP0101007A3 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
ZA964819B (en) Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds.
TR200103455T2 (tr) Cinsiyet steroidi öncüleri ile kombinasyon halindeki bir selektif östrojen reseptör modülatörünün tıbbi kullanımları
CA2467222A1 (en) Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
BRPI0516243C1 (pt) uso de um precursor de esteróide sexual selecionado do grupo que consiste em dehidroepiandrosterona, sulfato de dehidroepiandrosterona, androst-5-eno-3b,17b-diol e 4-androsten-3,17-diona, uso do referido precursor em 5 associação com um modulador de receptor de estrogênio seletivo para proteção uterina e da glândula mamária contra câncer, composição farmacêutica e kit
CA2050291A1 (en) Combination therapy for the treatment of estrogen sensitive diseases
AR011480A1 (es) ACIL-ANILIDAS SUSTITUIDAS CON RADICALES (HETERO) CICLICOS, NO ESTEROIDALES, CON ACTIVIDAD GESTÁGENA Y ANDRoGENA MIXTA.
KR960028919A (ko) 당 피막으로부터 스테로이드의 조절된 방출
ES2176190T3 (es) Inhibidores de la actividad de esteroides sexuales.
ES2174920T3 (es) Producto de combinacion para la contracepcion que contiene agentes antagonistas de progesterona y un agente gestageno.
CA2334702A1 (en) Pharmaceutical compositions and uses for androst-5-ene-3.beta.,17.beta.-diol
WO1996040728A3 (en) Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds
DK1272504T3 (da) 8.Beta-hydrocarbylsubstituerede östradiener til anvendelse som selektive östrogener
ATE271386T1 (de) Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält
CA2561839C (en) Multi-phase contraceptive preparation based on a natural estrogen
AP2001002054A0 (en) Use of biogenic estrogen sulfamates for hormone replacement therapy.
CA2448278A1 (en) Drug delivery system comprising a tetrahidroxilated estrogen for use in hormonal contraception
TR200002593T2 (tr) Yeni bir gebelik önleme kiti
Baciewicz Oral contraceptive drug interactions
IL156811A0 (en) Bisaryl derivatives and pharmaceutical compositions containing the same
DE69724796D1 (de) Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthalten
PE20010579A1 (es) Mesoprogestinas (modulares de receptores de progesterona) como componentes de anticonceptivos femeninos
HUT73234A (en) Hormonal agent for the treatment of acne
RS20050816A (en) Pure d-(17alpha)-13-ethyl-17-hydroxy- 18,19-dinopregn-4-ene- 20-yne-3-one-3e- and-3z-oxime isomers,as well as process for the synthesis of the mixture of isomers and the pure isomers
US3816406A (en) O-aryl oximes of 3-keto steroids
BR0116127A (pt) Composto, composição farmacêutica, uso de um composto, e, conjunto para a contracepção masculina